VIVIOPTAL VI-CAPS SUPRADYN CAMOVIT-M OCULUVIT EXTRA HONEYPLEX UNIVIT CALCIOL MULTINAF MULTIBIONTA-M MULTIBIONTA MULTIBIONTA CALCIUM-P UNICAP ROCALTROL ROCALTROL ROCALTROL ROCALTROL DIADYNAM-G CALTRIOL DELMIN PANHEMIC CALIBIN BONKY D-18 E-GEM CREAM ADE E-GEM SHAMPOO VIDAYLIN-M VIDAYLIN-M CALCIJEX CALCIWINS

Dose: 0.25 to 1 mcg
Single Dose: 0.62 (0.625)
Frequency: 24 hourly
Route: PO
Instructions:

Dose: 0.01 to 0.05 ug/kg
Single Dose: 0.03 (0.03)
Frequency: 24 hourly
Route: Oral
Instructions: -

Dose: 0.01 to 0.05 ug/kg
Single Dose: 0.03 (0.03)
Frequency: 24 hourly
Route: Oral
Instructions: -

Calcitriol also known as 1, 25 Dihydroxy Vitamin D3. Vitamin D is the derivative of Calcitriol. It is of Synthetic origin and belongs to Vitamin D. It belongs to Vitamin D agonist pharmacological group on the basis of mechanism of action and also classified in Vitamin D Analogue pharmacological group.The Molecular Weight of Calcitriol is 416.00.

Calcitriol is contraindicated in conditions like Hypercalcaemia.

The severe or irreversible adverse effects of Calcitriol, which give rise to further complications include Urinary calcium stone formation, Urinary calcium stone formation.Calcitriol produces potentially life-threatening effects which include Depression of CNS, Coma, Ectopic mineralization. which are responsible for the discontinuation of Calcitriol therapy.

Calcitriol is primarily indicated in conditions like Hypocalcaemia, Hypophosphataemia, Oncogenic hypophosphatemic osteomalacia, Renal tubular osteomalacia, Sporadic hypophosphatemic osteomalacia, Uraemic osteodystrophy, Uremic osteodystrophy, Vitamin D-dependent rickets, and can also be given in adjunctive therapy as an alternative drug of choice in Neonatal hypocalcemia, Osteomalacia, Osteomalacia in malabsorption syndrome, Osteoporosis, Psoriasis, Rickets in premature infants, X-linked hypophosphataemic osteomalacia.

Calcitriol is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAluminium Hydroxide and OxideCholestyramineColestipol (HCl)DigoxinVORICONAZOLEVoriconazole may increase the serum concentration of calcitriol by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of calcitriol if voriconazole is initiated, discontinued or dose changed. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Assay for plasma Vit. D metabolites (at high doses)

Drug should not be given to Paediatrics, patients suffering from Kidney dysfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Caps Store in a well closed container, Below 40°C. Protect from Heat.

Evaluate Vit.D administration in fortified food, diet and drugs. It may be necessary to limit dietary Vit.D during treatment. If products of Vit.D contain tartrazine may cause allergic reaction (Including bronchial asthma) in susceptible individuals, Specially patients with aspirin hypersensitivity.